WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria, including multidrug-resistant (MDR) gram-negative pathogens, today announced that the company will present at the 2011 BIO International Convention being held June 27 to 30 in Washington, D.C. at the Walter E. Washington Convention Center. Tetraphase President and Chief Executive Officer Guy Macdonald will participate in a panel entitled “Financing Beyond the Lead Compound: Attracting Funding for Multiproduct Platforms,” which will take place on Tuesday, June 28, from 10:00 a.m. until 11:30 a.m.
